SEC Form D · filed September 12, 2023
Osteal Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
David Cash · DALLAS, TXDirectorJudson Cooper · DALLAS, TXDirectorMartin Sands · DALLAS, TXDirectorBrian De Beaubien · DALLAS, TXDirectorRushu Luo · DALLAS, TXDirectorBiren Mehta · DALLAS, TXDirectorDavid Thompson · DALLAS, TXExec · DirectorDouglas Kohrs · DALLAS, TXDirectorDouglas Kohrs · DALLAS, TXDirectorBrian De Beaubien · DALLAS, TXDirectorDavid Thompson · DALLAS, TXExec · DirectorMartin Sands · DALLAS, TXDirectorDavid Cash · DALLAS, TXDirectorBiren Mehta · DALLAS, TXDirectorJudson Cooper · DALLAS, TXDirectorRushu Luo · DALLAS, TXDirectorLisa Merage · Newport Beach, CADirectorFred Brown · Vancouver, British Columbia, CanadaDirectorDarcy Cavanaugh · Vancouver, British Columbia, CanadaDirectorJustin J. Foo · Vancouver, British Columbia, CanadaDirectorKnox J. Henderson · Vancouver, British Columbia, CanadaExec · DirectorBrydon Cotter · Vancovuer, British Columbia, CanadaDirectorRyan Lewis · Vancouver, British Columbia, CanadaDirectorDeborah J. Cotter · Vancouver, British Columbia, CanadaDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗